http://cincluspharma.com/sv/ 2026-01-29T15:24:45+00:00 monthly 0.5 http://cincluspharma.com/sv/om-oss/ 2024-05-02T09:22:10+00:00 monthly 0.5 http://cincluspharma.com/sv/om-oss/bolagsstrategi/ 2026-01-29T14:03:48+00:00 monthly 0.5 http://cincluspharma.com/sv/om-oss/karriaer/ 2026-03-10T08:10:41+00:00 monthly 0.5 http://cincluspharma.com/sv/om-oss/karriaer/clinical-research-manager-with-extensive-experience-in-global-phase-iii-clinical-studies/ 2026-03-10T08:12:26+00:00 monthly 0.5 http://cincluspharma.com/sv/om-oss/licensierade-partners/ 2026-01-29T14:29:34+00:00 monthly 0.5 http://cincluspharma.com/sv/om-oss/styrelse/ 2026-01-27T14:16:55+00:00 monthly 0.5 http://cincluspharma.com/sv/om-oss/ledning/ 2026-03-23T08:05:24+00:00 monthly 0.5 http://cincluspharma.com/sv/vaar-forskning/ 2024-05-02T09:17:18+00:00 monthly 0.5 http://cincluspharma.com/sv/vaar-forskning/om-gerd/ 2025-10-03T13:54:33+00:00 monthly 0.5 http://cincluspharma.com/sv/vaar-forskning/om-gerd/patientberaettelse-att-leva-med-gerd/ 2025-04-01T13:32:11+00:00 monthly 0.5 http://cincluspharma.com/sv/vaar-forskning/om-gerd/patientberaettelse-vardagen-med-gerd/ 2023-01-20T10:47:18+00:00 monthly 0.5 http://cincluspharma.com/sv/vaar-forskning/linaprazan-glurate/ 2026-01-29T14:12:48+00:00 monthly 0.5 http://cincluspharma.com/sv/vaar-forskning/linaprazan-glurate/ppis-jaemfoert-med-pcabs/ 2025-10-02T14:28:04+00:00 monthly 0.5 http://cincluspharma.com/sv/vaar-forskning/utvecklingsstrategi/ 2025-10-03T08:12:11+00:00 monthly 0.5 http://cincluspharma.com/sv/vaar-forskning/klinisk-utveckling/ 2025-10-02T14:17:41+00:00 monthly 0.5 http://cincluspharma.com/sv/vaar-forskning/vetenskapliga-artiklar/ 2026-01-27T10:53:16+00:00 monthly 0.5 http://cincluspharma.com/sv/vaar-forskning/vetenskapliga-artiklar/2025/ 2026-01-26T15:04:58+00:00 monthly 0.5 http://cincluspharma.com/sv/vaar-forskning/vetenskapliga-artiklar/2025/clinical-trial-dose-finding-study-of-linaprazan-glurate-a-novel-potassium-competitive-acid-blocker-versus-lansoprazole-for-the-treatment-of-erosive-oesophagitis/ 2026-01-28T15:36:48+00:00 monthly 0.5 http://cincluspharma.com/sv/vaar-forskning/vetenskapliga-artiklar/2025/linaprazan-glurate-is-highly-effective-in-treating-moderate-to-severe-erosive-esophagitis-a-double-blind-randomized-dose-finding-study_abstract-ueg23_efficacy/ 2026-01-28T15:36:59+00:00 monthly 0.5 http://cincluspharma.com/sv/vaar-forskning/vetenskapliga-artiklar/2025/linaprazan-glurate-is-highly-effective-in-treating-moderate-to-severe-erosive-esophagitis-a-double-blind-randomized-dose-finding-study_abstract-ddw23/ 2026-01-28T15:37:05+00:00 monthly 0.5 http://cincluspharma.com/sv/vaar-forskning/vetenskapliga-artiklar/2025/linaprazan-glurate-is-well-tolerated-in-the-treatment-of-patients-with-erosive-esophagitis-a-double-blind-randomized-dose-finding-study_abstract-ueg23_safety/ 2026-01-28T15:37:10+00:00 monthly 0.5 http://cincluspharma.com/sv/vaar-forskning/vetenskapliga-artiklar/2025/optimised-biopharmaceutical-and-pharmacokinetic-properties-of-a-linaprazan-glurate-tablet-formulation-to-be-used-in-phase-3_abstract-ueg25/ 2026-01-28T15:37:15+00:00 monthly 0.5 http://cincluspharma.com/sv/vaar-forskning/vetenskapliga-artiklar/2025/optimised-biopharmaceutical-and-pharmacokinetic-properties-of-a-linaprazan-glurate-tablet-formulation-to-be-used-in-phase-3_ddw-25-_pk-abstract/ 2026-01-28T15:37:22+00:00 monthly 0.5 http://cincluspharma.com/sv/vaar-forskning/vetenskapliga-artiklar/2025/pharmacokinetics-and-pharmacodynamics-of-linaprazan-glurate-after-multiple-oral-doses-up-to-14-days-in-healthy-subjects_abstract-ueg24/ 2026-01-28T15:37:27+00:00 monthly 0.5 http://cincluspharma.com/sv/vaar-forskning/vetenskapliga-artiklar/2025/pharmacokinetics-and-pharmacodynamics-of-linaprazan-glurate-after-multiple-oral-doses-up-to-14-days-in-healthy-subjects_ddw-25-_pkpd-abstract/ 2026-01-28T15:37:32+00:00 monthly 0.5 http://cincluspharma.com/sv/vaar-forskning/vetenskapliga-artiklar/2025/pharmacokinetics-and-pharmacodynamics-of-linaprazan-glurate-aftermultiple-oral-doses-up-to-14-days-in-healthy-subjects_abstract-ddw24/ 2026-01-28T15:37:38+00:00 monthly 0.5 http://cincluspharma.com/sv/media/ 2025-06-11T11:00:45+00:00 monthly 0.5 http://cincluspharma.com/sv/media/pressreleaser/ 2023-01-13T15:59:39+00:00 monthly 0.5 http://cincluspharma.com/sv/media/pressreleaser/press-sida/ 2023-01-09T14:12:49+00:00 monthly 0.5 http://cincluspharma.com/sv/media/pressreleaser/disclaimer/ 2024-05-10T13:54:44+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/ 2025-07-02T14:19:28+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/fraan-sommarjobb-till-banbrytande-forskning/ 2026-03-26T13:34:48+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/magnus-christensen-ny-finanschef-paa-cinclus-pharma/ 2026-03-23T08:33:55+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/clinical-research-manager-with-extensive-experience-in-global-phase-iii-clinical-studies/ 2026-03-09T10:55:54+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/vi-vaelkomnar-patrik-norgren-som-tillfoerordnad-finanschef/ 2025-12-16T13:11:32+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/nu-kan-du-se-inspelningen-av-cinclus-pharmas-virtuella-kol-event/ 2025-12-11T20:17:29+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/vd-christer-alhberg-presenterar-paa-redeye-life-science-day-2025/ 2025-12-05T15:11:37+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/cinclus-pharma-bjuder-in-till-kol-event/ 2025-11-26T09:46:14+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/cinclus-pharmas-vd-christer-ahlberg-i-intervju-med-redeye-om-fas-iii-studien-och-q3-rapporten/ 2025-11-20T16:43:35+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/se-hela-presentationen-fraan-redeye-investor-forum/ 2025-10-13T16:23:24+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/cinclus-pharma-deltar-paa-redeye-investor-forum-i-goeteborg/ 2025-11-24T14:00:12+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/biotech-tv-intervjuar-christer-ahlberg/ 2025-09-18T15:05:34+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/cinclus-pharma-paa-aktiedagarna-i-stockholm/ 2025-10-29T09:25:35+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/cinclus-pharmas-vd-christer-ahlberg-i-intervju-med-efn-ekonomikanalen/ 2025-09-18T15:18:30+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/en-laekares-perspektiv-paa-linaprazan-glurates-unika-potential/ 2025-07-30T08:00:59+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/nina-rawal-trill-impact-ventures-om-investeringen-i-cinclus-pharma/ 2025-07-16T08:00:23+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/kajsa-larsson-cmo-om-de-kommande-fas-iii-studierna-med-linaprazan-glurate/ 2025-07-10T09:14:23+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/tillgodoser-ett-otillfredsstaellt-medicinskt-behov-inom-gerd/ 2025-08-27T08:00:37+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/ett-paradigmskifte-drivet-av-syrakontroll/ 2025-09-10T08:00:05+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/se-presentationen-fraan-biostock-global-forum/ 2025-05-26T16:09:33+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/intervju-paa-redeye-om-partnerskapet-med-zentiva/ 2025-05-22T14:47:56+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/cinclus-pharma-ingaar-partnerskap-med-zentiva-foer-att-kommersialisera-linaprazan-glurate-i-europa/ 2025-05-22T07:59:57+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/presentation-paa-nordea-equities-healthcare-seminar/ 2025-05-08T14:48:51+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/cinclus-pharma-deltar-paa-biostock-global-forum-i-lund-sverige-den-21-maj/ 2025-05-08T07:36:03+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/bengt-julander-om-cinclus-pharma-i-ditv/ 2024-12-11T16:20:19+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/cinclus-pharma-at-redeye-technology-life-science-day/ 2024-12-05T11:28:15+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/cinclus-pharma-paa-avanzas-boersdag/ 2024-11-29T13:31:20+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/nyhetsbyraan-direkt-omcinclus-pharma/ 2024-11-28T20:04:02+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/cinclus-pharma-paa-stora-aktiedagarna/ 2024-11-28T17:51:09+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/se-presentationen-fraan-redeye-investor-forum-10-oktober/ 2024-10-11T16:11:54+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/cinclus-pharma-paa-redeye-investor-forum-i-goeteborg/ 2024-09-30T11:12:55+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/cinclus-pharmas-vd-christer-ahlberg-intervjuad-av-redeye/ 2024-09-25T16:25:45+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/se-presentationen-fraan-redeye-investor-forum-online-19-september/ 2024-09-20T09:41:40+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/cinclus-pharma-paa-redeye-investor-forum-online-den-19-september/ 2024-09-18T11:16:02+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/se-presentationen-fraan-aktiespararnas-event-den-17-september/ 2024-09-18T09:43:37+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/cinclus-pharma-deltar-paa-aktiespararnas-event-den-17-september/ 2024-09-18T11:16:26+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/laes-hela-analysen-av-cinclus-pharma-i-artikeln-av-boersveckan/ 2024-07-15T09:04:18+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/intervju-med-christer-ahlberg-vd-foer-cinclus-pharma-efter-noteringen/ 2024-07-12T10:10:20+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/intervju-med-christer-ahlberg-vd-foer-cinclus-pharma-i-boerspodden/ 2024-06-26T13:46:13+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/hoejdpunkter-fraan-dagens-boersintroduktion-paa-nasdaq-stockholm/ 2024-06-20T14:29:38+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/stort-intresse-foer-noteringen-intervju-med-vd-christer-ahlberg/ 2024-06-19T17:47:47+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/foersta-dag-foer-handel-i-cinclus-pharmas-stamaktier-paa-nasdaq-stockholm/ 2024-06-20T07:44:50+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/intervju-med-cinclus-pharmas-vd-christer-ahlberg-i-boerslunch-om-den-kommande-noteringen/ 2024-06-19T15:04:30+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/intervju-med-christer-ahlberg-vd-foer-cinclus-pharma-i-trading-direkt/ 2024-06-27T14:50:56+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/christer-ahlberg-vd-foer-cinclus-pharma-i-intervju-med-nordnet/ 2024-06-19T11:13:41+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/intervju-med-christer-ahlberg-vd-foer-cinclus-pharma-i-penserpodden/ 2024-06-19T10:59:59+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/presentation-av-bolaget-och-utvecklingen-av-linaprazan-glurate-fraan-redeye-transactions/ 2024-06-14T12:59:41+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/presentation-av-bolaget-och-utvecklingen-av-linaprazan-glurate-fraan-aktiespararnas-event/ 2024-06-13T09:33:11+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/cinclus-pharma-offentliggoer-notering-paa-nasdaq-stockholm-och-erbjudande-av-stamaktier-samt-publicerar-tillhoerande-prospekt/ 2024-06-13T08:59:59+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/christers-presentation-fraan-redeye-growth-day-2024/ 2024-06-19T16:10:57+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/redeye-growth-day-2024-30-maj/ 2024-05-24T12:28:08+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/cinclus-pharma-deltar-paa-aktiespararnas-event-smaabolagsdagarna-den-12-juni/ 2024-05-28T09:37:30+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/abgsc-investor-days/ 2024-05-27T12:18:57+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/presentation-av-bolaget-och-utvecklingen-av-linaprazan-glurate-fraan-avanzas-boersdag/ 2024-06-13T09:22:02+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/cinclus-pharma-deltar-paa-avanzas-boersdag/ 2024-05-13T15:46:33+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/cinclus-pharma-paa-redeye-investor-forum-i-goeteborg-18-april-2024/ 2024-09-18T11:18:53+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/cinclus-pharma-presenterade-paa-abgsc-investor-days/ 2023-12-04T15:43:25+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/cinclus-pharma-meddelar-positivt-fda-besked/ 2023-11-23T08:42:37+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/lennart-hansson-visionaer-och-erfaren-styrelseordfoerande-foer-cinclus-pharma/ 2023-06-30T15:43:23+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/cinclus-pharma-paa-abgsc-life-science-summit-2023/ 2023-06-02T11:47:56+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/nina-rawal-paa-trill-impact-ventures-om-investeringen-i-cinclus-pharma/ 2023-05-10T08:12:55+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/malin-filler-senior-regulatory-affairs-manager-med-maalet-att-faa-linaprazan-glurate-registrerat-som-laekemedel/ 2023-05-08T11:50:13+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/kajsa-larsson-erfaren-cmo-med-patientsaekerhet-i-fokus/ 2023-04-14T09:01:13+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/christer-ahlberg-presenterade-cinclus-pharma-paa-stora-aktiedagen-i-stockholm/ 2023-01-12T08:03:50+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/christer-ahlberg-presenterar-cinclus-pharma-paa-stora-aktiedagen-i-goeteborg/ 2023-01-12T08:04:07+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/sista-patienten-ut-fraan-fas-ii-studien-av-linaprazan-glurate/ 2023-01-16T16:40:21+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/goesta-hiller-driven-ledare-som-vill-bygga-smarta-team-och-se-maenniskor-vaexa-tillsammans/ 2023-02-03T12:15:55+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/cinclus-pharma-paa-abgsc-life-science-summit/ 2023-01-09T14:12:48+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/christer-ahlberg-om-cinclus-pharmas-nutid-och-framtid/ 2023-01-09T14:12:48+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/intervju-med-kjell-andersson-i-life-science-sweden/ 2023-01-09T14:12:48+00:00 monthly 0.5 http://cincluspharma.com/sv/media/i-fokus/foerbaettrar-livskvaliteten-foer-personer-som-lider-av-gerd/ 2023-01-09T14:12:48+00:00 monthly 0.5 http://cincluspharma.com/sv/media/prenumerera/ 2023-01-13T16:00:39+00:00 monthly 0.5 http://cincluspharma.com/sv/media/mediagalleri/ 2025-04-02T08:56:16+00:00 monthly 0.5 http://cincluspharma.com/sv/media/mediagalleri/personer/ 2024-04-25T16:31:15+00:00 monthly 0.5 http://cincluspharma.com/sv/media/mediagalleri/personer/christer-ahlberg-ceo/ 2026-02-03T16:09:19+00:00 monthly 0.5 http://cincluspharma.com/sv/media/mediagalleri/personer/goesta-hiller-coo/ 2026-01-30T09:43:53+00:00 monthly 0.5 http://cincluspharma.com/sv/media/mediagalleri/personer/kajsa-larsson-cmo/ 2026-02-03T15:28:15+00:00 monthly 0.5 http://cincluspharma.com/sv/media/mediagalleri/personer/kjell-andersson-styrelseledamot-medgrundare-cso/ 2026-02-10T10:42:19+00:00 monthly 0.5 http://cincluspharma.com/sv/media/mediagalleri/personer/malin-filler-regulatorisk-chef/ 2026-01-30T09:44:06+00:00 monthly 0.5 http://cincluspharma.com/sv/media/mediagalleri/personer/bengt-erlandsson-chef-foer-cmc-och-ip/ 2026-01-30T09:44:59+00:00 monthly 0.5 http://cincluspharma.com/sv/media/mediagalleri/personer/peter-wallich-kommersiell-chef/ 2026-02-03T15:28:57+00:00 monthly 0.5 http://cincluspharma.com/sv/media/mediagalleri/personer/lennart-hansson-styrelseordfoerande-medgrundare/ 2026-02-10T10:44:00+00:00 monthly 0.5 http://cincluspharma.com/sv/media/mediagalleri/personer/wenche-rolfsen-styrelseledamot/ 2026-02-10T10:44:35+00:00 monthly 0.5 http://cincluspharma.com/sv/media/mediagalleri/personer/torbjoern-koivisto-styrelseledamot/ 2026-02-10T10:45:37+00:00 monthly 0.5 http://cincluspharma.com/sv/media/mediagalleri/personer/anders-oehberg-styrelseledamot/ 2026-02-10T10:46:09+00:00 monthly 0.5 http://cincluspharma.com/sv/media/mediagalleri/personer/helena-levander-styrelseledamot/ 2026-02-10T10:46:44+00:00 monthly 0.5 http://cincluspharma.com/sv/media/mediagalleri/personer/nina-rawal-styrelseledamot/ 2026-02-10T10:47:23+00:00 monthly 0.5 http://cincluspharma.com/sv/media/mediagalleri/personer/magnus-christensen-finanschef/ 2026-03-23T08:22:36+00:00 monthly 0.5 http://cincluspharma.com/sv/media/mediagalleri/logotyper/ 2023-01-09T14:12:50+00:00 monthly 0.5 http://cincluspharma.com/sv/media/mediagalleri/logotyper/cinclus-pharma-logotyp/ 2022-05-13T13:34:15+00:00 monthly 0.5 http://cincluspharma.com/sv/media/mediagalleri/logotyper/cinclus-pharma-logotyp-horisontell/ 2022-05-13T13:34:36+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/ 2025-04-02T08:57:39+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2025/ 2025-01-02T14:26:08+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2025/kjell-andersson-i-lonza-podcast-a-view-on-developing-acid-reflux-therapy/ 2025-03-07T14:57:54+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2025/placerase-listar-svenska-aktier-med-stoerst-uppsida/ 2025-01-02T14:27:07+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2024/ 2024-06-10T10:06:49+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2024/bengt-julander-om-cinclus-pharma-i-ditv/ 2024-12-11T15:34:45+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2024/nyhetsbyraan-direkt-om-cinclus-pharma-ca-80-90-av-potential-linaprazan-glurate-i-usa/ 2024-11-29T11:42:12+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2024/cinclus-pharmas-vd-christer-ahlberg-intervjuad-av-redeye/ 2024-09-25T16:30:42+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2024/intervju-med-christer-ahlberg-vd-foer-cinclus-pharma-i-boerspodden/ 2024-09-13T10:00:20+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2024/christer-ahlberg-ceo-foer-cinclus-pharma-deltar-i-efn-boerslunch/ 2024-06-18T13:26:09+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2024/intervju-med-christer-ahlberg-vd-paa-cinclus-pharma-i-trading-direkt/ 2024-06-18T13:22:00+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2024/christer-ahlberg-vd-foer-cinclus-pharma-i-intervju-med-nordnet/ 2024-06-18T10:49:34+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2024/intervju-med-christer-ahlberg-vd-foer-cinclus-pharma-i-penserpodden/ 2024-06-19T10:55:27+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2024/cinclus-pharma-ipo-i-raett-fas/ 2024-06-13T08:54:46+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2024/laekemedels-vdn-om-noteringen-vi-aer-ett-laagriskprojekt/ 2024-06-11T08:46:27+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2024/cinclus-pharma-till-boersen-foersta-handelsdag-naesta-vecka/ 2024-06-10T17:01:32+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2024/cinclus-pharma-siktar-paa-nasdaq-stockholm/ 2024-06-10T16:56:21+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2024/cinclus-pharma-till-boersen-raeknar-med-godkaent-laekemedel-2029/ 2024-06-10T16:52:39+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2024/placera-cinclus-pharma-till-boersen/ 2024-06-10T16:49:47+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2024/cinclus-pharma-holding-ab-plans-to-list-on-nasdaq-inc-in-stockholm-next-week/ 2024-06-17T09:42:26+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2024/dis-uppgifter-bekraeftade-cinclus-pharma-till-boersen/ 2024-06-10T10:07:10+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2021/ 2022-11-08T10:03:54+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2021/intervju-med-kjell-andersson-cso-i-life-science-sweden/ 2022-11-08T10:06:47+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2022/ 2022-05-25T08:30:16+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2022/nya-forskningsframsteg-foer-linc-aegt-laekemedelsbolag/ 2022-11-08T10:11:19+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2022/cinclus-pharma-tar-in-en-kvarts-miljard-eqt-grundare-bland-investerarna/ 2022-11-08T10:10:38+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2022/cinclus-tar-in-240-miljoner-till-losecuppfoeljare/ 2022-11-08T10:09:52+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2022/telegram-bengt-julanders-linc-investerar-i-cinclus-pharma-avanza/ 2022-11-08T10:09:02+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2022/telegram-cinclus-pharma-tar-in-240-miljoner-kronor/ 2022-11-08T10:09:14+00:00 monthly 0.5 http://cincluspharma.com/sv/media/cinclus-pharma-i-media/2022/staahlberg-ibland-investerarna-i-boerskandidat-som-tar-in-en-kvarts-miljard/ 2022-11-08T10:06:51+00:00 monthly 0.5 http://cincluspharma.com/sv/kontakt/ 2025-09-09T16:10:36+00:00 monthly 0.5 http://cincluspharma.com/sv/soek/ 2021-12-09T18:04:52+00:00 monthly 0.5 http://cincluspharma.com/sv/integritetspolicy/ 2026-02-04T11:25:37+00:00 monthly 0.5 http://cincluspharma.com/sv/disclaimer/ 2024-06-10T09:20:11+00:00 monthly 0.5